COVID-19 rapid test EasyCOV
salivaclinicalmolecular

COVID-19 rapid test
COVID-19 rapid test
COVID-19 rapid test
COVID-19 rapid test
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Sample type
saliva, clinical
Analysis mode
molecular

Description

EASYCOV : RAPID AND RELIABLE SALIVARY SCREENING TEST FOR COVID-19 Sensitivity: 86% – Specificity: 99% validated by a clinical study, same performance on the new variants Tame-Care, SkillCell and Alcediag (Sys2Diag / CNRS), and VOGO have pooled their expertise to develop a global saliva screening solution called EasyCOV®. Co-developed with the CNRS,this test dedicated to the fight against the Covid-19 pandemic is based on the analysis of saliva and provides a reliable result in 40 minutes. ADVANTAGES •Reliable - 86% sensitivity and 99% specificity, including on the variants detected to date. •Comfortable and painless- A simple saliva sample •Field - Its ready-to-use consumables and its implementation device (EasyVID) can be transported to the operational environment •Fast - A test result in 40 min. •Simple - Simple visual interpretation through colour recognition. This saliva test, marketed internationally from June 2020, was approved in France by the HAS in December 2020 and is now reimbursable since January 2021. APPLICATIONS The EasyCOV test and its EasyVID® implementation device, offers the ability to easily deploy Covid-19 test points in different locations: • Airports • Ports • Stations • Establishments opening to the public • Companies, • Concert halls • Sports clubs • ... If you are interested in ordering or distributing this solution, please contact us.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.